Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Savitri Krishnamurthy

Showing results (221-230 of 262) with videos related to

Pageof 27
Sort By:
Molecular Cancer|July 10, 2010
Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cellsBisrat G Debeb, Xiaomei Zhang, Savitri Krishnamurthy, et al.
Molecular Oncology|August 3, 2021
Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasionEmilly S Villodre, Xiaoding Hu, Richard Larson, et al.
Cancer|February 6, 2003
Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapyFunda Meric, Nadeem Q Mirza, Georges Vlastos, et al.
Breast Cancer Research : BCR|November 27, 2013
Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancersHiroko Masuda, Keith A Baggerly, Ying Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2014
Influence of biospecimen variables on proteomic biomarkers in breast cancerFunda Meric-Bernstam, Argun Akcakanat, Huiqin Chen, et al.
Breast Cancer Research : BCR|May 6, 2025
AXL promotes inflammatory breast cancer progression by regulating immunosuppressive macrophage polarizationLan T H Phi, Yating Cheng, Yohei Funakoshi, et al.
Breast Cancer Research and Treatment|July 9, 2021
Nonphosphorylatable PEA15 mutant inhibits epithelial-mesenchymal transition in triple-negative breast cancer partly through the regulation of IL-8 expressionJihyun Park, Moises J Tacam, Gaurav Chauhan, et al.
Plos One|October 13, 2018
Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtypeKenichi Harano, Ying Wang, Bora Lim, et al.
Breast Cancer Research and Treatment|August 2, 2025
Neoadjuvant HER2-targeted regimens with or without anthracyclines for HER2-positive inflammatory breast cancer: a multicenter retrospective studyToshiaki Iwase, Nithya Sridhar, Megumi Kai, et al.
Human Pathology|April 12, 2022
TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinomaEsther C Yoon, Gang Wang, Bryce Parkinson, et al.
Pageof 27

Showing results (221-230 of 262) with videos related to

Sort By:
Pageof 27
Molecular Cancer|July 10, 2010
Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cellsBisrat G Debeb, Xiaomei Zhang, Savitri Krishnamurthy, et al.
Molecular Oncology|August 3, 2021
Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasionEmilly S Villodre, Xiaoding Hu, Richard Larson, et al.
Cancer|February 6, 2003
Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapyFunda Meric, Nadeem Q Mirza, Georges Vlastos, et al.
Breast Cancer Research : BCR|November 27, 2013
Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancersHiroko Masuda, Keith A Baggerly, Ying Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2014
Influence of biospecimen variables on proteomic biomarkers in breast cancerFunda Meric-Bernstam, Argun Akcakanat, Huiqin Chen, et al.
Breast Cancer Research : BCR|May 6, 2025
AXL promotes inflammatory breast cancer progression by regulating immunosuppressive macrophage polarizationLan T H Phi, Yating Cheng, Yohei Funakoshi, et al.
Breast Cancer Research and Treatment|July 9, 2021
Nonphosphorylatable PEA15 mutant inhibits epithelial-mesenchymal transition in triple-negative breast cancer partly through the regulation of IL-8 expressionJihyun Park, Moises J Tacam, Gaurav Chauhan, et al.
Plos One|October 13, 2018
Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtypeKenichi Harano, Ying Wang, Bora Lim, et al.
Breast Cancer Research and Treatment|August 2, 2025
Neoadjuvant HER2-targeted regimens with or without anthracyclines for HER2-positive inflammatory breast cancer: a multicenter retrospective studyToshiaki Iwase, Nithya Sridhar, Megumi Kai, et al.
Human Pathology|April 12, 2022
TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinomaEsther C Yoon, Gang Wang, Bryce Parkinson, et al.
Pageof 27